Seventy-five patients affected by chronic constipation were treated for 4 weeks with an Ispaghula Husk preparation (Fibrolax®), a bulk-forming laxative.
Frequency, stool consistency, abdominal pain and signs of venous stasis improved after treatment. No important side-effect was recorded. Cholesterol, HDL-cholesterol and triglycerides did not show significant changes.
Get full access to this article
View all access options for this article.
References
1.
ArmitageP (1974) Statistical methods in medical research. Blackwell Scient. Publ.
2.
BurkittDPStewartCW Graham (1975) Haemorroids: postulated pathogenesis and proposed prevention. Postgraduate Medical Journal51, 631
3.
FagerbergS (1982) The effects of a bulk laxative (Metamucil®) on fasting blood glucose, serum lipids and other variables in constipated patients with non-insulin dependent adult diabetes. Current Therapeutic Research31, 166
4.
FinglE (1980) Laxatives and cathartics. In: Goodman and Gilman'sThe Pharmacological Basis of Therapeutics. MacMillan publ. New York, Sixth edition. 1002
5.
LieberthalMMMartensRA (1975) Lowered serum cholesterol following the ingestion of a hydrophilic colloid. Digestive Diseases20, 469
6.
RitchieJATrueloveSC (1979) Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide and Ispagula Husk. British Medical Journal1, 376
7.
RivelleseA (1980) Effect of dietary fibre on glucose control and serum lipoproteins in diabetic patients. Lancet2, 447
8.
TarpilaSMiettinenTA (1977) Effects of plantago fibre on serum lipids and fecal composition in hypercholesterolaemic patients. Scandinavian Journal of Gastroenterology12, suppl. 45, 105
9.
TarpilaSMiettinenTAMetsarantaL (1978) Effects of bran on serum cholesterol, faecal mass fat, bile acids and neutral sterols, and biliary lipids in patients with diverticular disease of the colon. Gut19, 137
